PhosphoSens ABL2 Protein Kinase Assays, Substrates & Recombinant Enzymes

Continuous, real-time assays that directly quantify ABL2 catalytic activity — generating a full progress curve in every well for IC₅₀, mechanism, and selectivity studies.

  • Real-time kinetic or TRF endpoint formats
  • Optimized substrates and assay-ready kits
  • Compatible with physiological ATP and cofactors

Designed for: drug discovery, lead optimization, and mechanistic kinase research teams

 

PhosphoSens ABL2 kinase assay kit — continuous real-time fluorescence

About ABL2

ABL2 (also known as ARG, Abelson-related gene) is a non-receptor tyrosine kinase belonging to the Abl family, which also includes the closely related ABL1. ABL2 contains SH2 and SH3 domains that regulate its kinase activity through intramolecular autoinhibitory interactions, and its activation is governed by relief of this autoinhibition via phosphorylation, protein-protein interactions, or oncogenic fusion events. Key substrates include cortactin, p190RhoGAP, and various actin-regulatory proteins, linking ABL2 to cytoskeletal remodeling, cell migration, and invasion. ABL2 signals through the RAS/MAPK, PI3K/AKT, and Rho GTPase pathways to control proliferation and survival. Aberrant ABL2 activity has been implicated in solid tumors including breast, colorectal, and brain cancers, as well as leukemia via chromosomal translocations generating oncogenic fusion kinases. The kinase domain of ABL2 shares high homology with ABL1, making it a co-target of clinically proven ABL inhibitors and an important drug discovery target in its own right for both hematologic malignancies and metastatic solid tumors.

Why PhosphoSens for ABL2?

Profiling ABL2 kinase activity presents several assay challenges: its autoinhibitory regulation demands careful attention to enzyme activation state, and high substrate selectivity requires well-validated peptide substrates. Traditional endpoint methods such as ADP-Glo and HTRF can miss transient kinetic phenomena, are susceptible to compound interference, and require fixed ATP concentrations far above physiological levels, distorting IC50 values for ATP-competitive inhibitors. Radiometric assays add radioactive handling burdens and poor throughput. PhosphoSens continuous fluorescent assays monitor ABL2-mediated substrate phosphorylation in real time using physiological ATP concentrations, generating complete progress curves that reveal mechanism of action, detect covalent inhibitors through kinact/KI determination, and eliminate endpoint artifacts. This approach enables robust selectivity profiling against ABL1 and enables higher-quality SAR decisions during lead optimization campaigns targeting ABL2.

Key Pathways: RAS/MAPK signaling PI3K/AKT signaling Rho GTPase/actin cytoskeleton remodeling BCR-ABL oncogenic signaling
Approved Inhibitors:
Imatinib (Gleevec, CML/Ph+ ALL Dasatinib (Sprycel, CML/Ph+ ALL Nilotinib (Tasigna, CML Bosutinib (Bosulif, CML Ponatinib (Iclusig, CML/Ph+ ALL Asciminib (Scemblix, CML)

Talk to a Scientist

Have questions about ABL2 assay design, selectivity panels, or covalent inhibitor characterization?

Ask Our Scientists →
How pricing works:
Select a kit or substrate below, then request a quote. Bundle discounts apply automatically.

Real-Time ABL2 Activity Assays

Continuous, real-time fluorescent assays optimized for quantitative ABL2 activity measurements, IC50 determination, and mechanistic studies.

Assay Format: Continuous kinetic fluorescence (real-time)

PhosphoSens-Kinetic assays directly quantify enzyme activity by continuously monitoring substrate phosphorylation or dephosphorylation in real time, generating a full progress curve in every well.

Learn more about PhosphoSens-Kinetic →

Need pricing or availability? Select a kit or substrate to request a quote below.

Kits

PhosphoSens-Kinetic Kinase Activity Kit - AQT0032

Ready-to-use assay kits containing substrate and all essential reagents.

Kit Contents
  • Optimized PhosphoSens® substrate (AQT0032)
  • ATP, DTT, EGTA, Reaction Buffer & Dilution Buffer

Automatically save 10% when bundling 10ug recombinant enzyme with your 1,000 assay kit. View enzymes

Price: $425

Substrate

PhosphoSens Kinase Substrate AQT0032

Bulk PhosphoSens® substrate for assay development and high-throughput workflows.

Specifications

Automatically save 10% when bundling Reagent Packs with your substrate. View Reagent Packs

Price: $2795

Ready to request pricing for ABL2?

Select a kit, substrate, or enzyme above. Our team will confirm pricing, availability, and any applicable bundle discounts.

Request a Quote

TRF ABL2 Screening Assays

Robust endpoint TRF assays optimized for high-throughput screening and quantitative ABL2 activity measurement in plate-based workflows.

Assay Format: Time-resolved fluorescence (TRF, endpoint)

PhosphoSens-Red assays use europium-based time-resolved fluorescence detection to enable robust, plate-based quantification of enzyme activity, making them well suited for high-throughput screening workflows.

Learn more about PhosphoSens-Red →

Need pricing or availability? Select a kit or substrate to request a quote below.

Kits

PhosphoSens-Red Kinase Activity Kit - AQT0030

Ready-to-use TRF assay kits containing substrate and essential reagents.

Kit Contents
  • Optimized PhosphoSens® substrate (AQT0030)
  • ATP, DTT, EGTA, Reaction Buffer & Dilution Buffer
  • Europium Detection Solution

Automatically save 10% when bundling 10ug recombinant enzyme with your 1,000 assay kit. View enzymes

Price: $455

Substrate

PhosphoSens Kinase Substrate AQT0030

Bulk substrate for PhosphoSens-Red TRF assays and high-throughput workflows.

Specifications

Automatically save 10% when bundling Reagent Packs with your substrate. View Reagent Packs

Price: $2795

Ready to request pricing for ABL2?

Select a kit, substrate, or enzyme above. Our team will confirm pricing, availability, and any applicable bundle discounts.

Request a Quote

Active Recombinant Enzymes for ABL2

Wild-type and mutant forms of ABL2 for assay development, kinase profiling, and mechanistic studies. Enzymes are supplied active and optimized for PhosphoSens® substrates.

ABL2, Active

Human • Baculovirus-Insect Cells

Technical Specifications
  • Catalog: AQT-A04-11H
  • Species: Human
  • Expression System: Baculovirus-Insect Cells
  • Storage Buffer: Supplied as sterile 50 mM sodium phosphate, pH 7.5, 300mM NaCl, 50-200mM imidazole, 0-0.1mM PMSF, 0.2-1.0mM DTT, 10-25% glycerol
  • Molecular Weight: ~132 kDa
  • Purity/Activity: For specific information on a given lot, see related technical data sheet.
  • Storage Conditions: Store product at -70°C. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles.
Available Sizes:

Price: $$348.00

Request a Quote
🔬 150+ peer-reviewed citations · 🏛️ MIT spinout technology · ⚗️ PhosphoSens® validated by independent labs worldwide · Browse technical articles →

Frequently Asked Questions: ABL2 Assays

How does AssayQuant's PhosphoSens assay measure ABL2 kinase activity continuously?

PhosphoSens uses proprietary chelation-enhanced fluorescent (CHEF) peptide substrates that produce a real-time fluorescent signal change upon phosphorylation by ABL2, eliminating the need for antibodies or secondary detection reagents. This generates complete kinetic progress curves from a single reaction well, enabling precise rate measurements and mechanistic characterization. The approach is compatible with physiological ATP concentrations, providing more biologically relevant inhibitor potency data.

Can PhosphoSens assays distinguish ABL2 inhibitors from ABL1 inhibitors in selectivity profiling?

Yes, AssayQuant offers optimized substrate and assay conditions for both ABL1 and ABL2, enabling direct head-to-head selectivity profiling within the same fluorescent assay platform. Because both assays run under matched physiological ATP conditions, IC50 values are directly comparable across the two kinases. This is critical for developing isoform-selective inhibitors or understanding the dual-targeting profile of clinical Abl inhibitors.

Is the PhosphoSens ABL2 assay suitable for characterizing covalent inhibitors?

Absolutely. The continuous, real-time nature of PhosphoSens progress curves makes it uniquely suited for determining kinact/KI parameters that define covalent inhibitor efficiency, something endpoint assays like ADP-Glo or HTRF cannot reliably capture. By monitoring the time-dependent loss of ABL2 activity in a single kinetic experiment, researchers can rapidly distinguish covalent from reversible mechanisms and rank covalent warhead efficiency during lead optimization.

Data & Resources

Explore data and documents to support your kinase and phosphatase experiments. Download sample data, protocols and other resources to see how our assays perform and to help you get started in your own lab. All validation data generated using PhosphoSens® assays under recommended conditions.

Still have questions about our products?

Our scientists can help you choose the right assay format, substrate, and enzyme for your experiment.

Stay Informed

Want to hear the latest about our technology? Be among the first to learn about our latest products and services.